- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.11: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: N.328, P.576, Q.577
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: G.598, N.600, T.601
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.613, T.615
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: Y.652, N.654
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.706
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.1071
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: Y.348
- Chain B: N.159, N.160
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain A: S.456, K.459, E.462
- Chain B: I.230, N.231
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.277, E.278, N.279
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: N.328, I.329
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: N.600, T.601
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.613, T.615
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.706
- Chain C: I.791, Y.793
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: K.555
Ligand excluded by PLIPNAG.30: 7 residues within 4Å:- Chain C: S.110, K.111, E.130, Q.132, S.157, N.159, N.160
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: T.106, I.230, N.231, T.233
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.61
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: N.613, T.615
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: N.706, G.1128
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: E.1069, N.1071
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yao, H. et al., A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains. MedComm (2020) (2023)
- Release Date
- 2023-12-13
- Peptides
- Spike glycoprotein: ABC
Nb4 nanobody: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yao, H. et al., A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains. MedComm (2020) (2023)
- Release Date
- 2023-12-13
- Peptides
- Spike glycoprotein: ABC
Nb4 nanobody: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E